Our Guest:
Stuart Gitlow, MD, MPH, MBA
Partner, CMO at Limitless Ventures- GP LLC
Past President of American Society of Addiction Medicine
Dr. Stuart Gitlow, a physician with 30 years of addiction medicine experience, shares the benefits of buprenorphine treatment he has observed in his own practice. He takes us through the fascinating history of the DATA Waiver (X-Waiver) and how the elimination of the requirement will impact care and prescribing. I really enjoyed this conversation and I think you will as well.
For more information on Drug Diversion mitigation and resources, visit: https://www.rxpert.solutions/
#drugdiversion #hospitalpharmacy #opioidcrisis #hospitalworker
